Broad-range neutralizing anti-influenza a human monoclonal antibodies: New perspectives in therapy and prophylaxis

Nicola Clementi, Elena Criscuolo, Matteo Castelli, Massimo Clementi

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Broadly neutralizing monoclonal antibodies (mAbs) directed against different subtypes of influenza A viruses are novel tools for the potential development of effective anti-influenza prophylactic and therapeutic strategies. In both cases, the main candidates for passive transfer and new vaccine development are represented by protective mAbs directed against influenza hemagglutinin (HA). A large number of mAbs directed against influenza HA has been developed to date. However, even if they can be useful and contribute to develop new vaccinal strategies, only few of them can be a good candidate for human administration. In this review, we will describe the most relevant human mAb directed against influenza HA able to recognize highly divergent influenza isolates and possibly useful for human therapy and prophylaxis.

Original languageEnglish
Pages (from-to)399-406
Number of pages8
JournalNew Microbiologica
Volume35
Issue number4
Publication statusPublished - 2012

Fingerprint

Human Influenza
Monoclonal Antibodies
Hemagglutinins
Therapeutics
Influenza A virus
Neutralizing Antibodies
Vaccines

Keywords

  • Antigenic drift
  • Antigenic shift
  • Bio-panning
  • Epitope characterization
  • Heterosubtypic immunity
  • Homologus immunity
  • Homosubtypic immunity
  • Monoclonal antibody
  • Neutralizing antibody
  • Phage display

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Broad-range neutralizing anti-influenza a human monoclonal antibodies : New perspectives in therapy and prophylaxis. / Clementi, Nicola; Criscuolo, Elena; Castelli, Matteo; Clementi, Massimo.

In: New Microbiologica, Vol. 35, No. 4, 2012, p. 399-406.

Research output: Contribution to journalArticle

@article{cc55f3eab4484e968fee56d649934aac,
title = "Broad-range neutralizing anti-influenza a human monoclonal antibodies: New perspectives in therapy and prophylaxis",
abstract = "Broadly neutralizing monoclonal antibodies (mAbs) directed against different subtypes of influenza A viruses are novel tools for the potential development of effective anti-influenza prophylactic and therapeutic strategies. In both cases, the main candidates for passive transfer and new vaccine development are represented by protective mAbs directed against influenza hemagglutinin (HA). A large number of mAbs directed against influenza HA has been developed to date. However, even if they can be useful and contribute to develop new vaccinal strategies, only few of them can be a good candidate for human administration. In this review, we will describe the most relevant human mAb directed against influenza HA able to recognize highly divergent influenza isolates and possibly useful for human therapy and prophylaxis.",
keywords = "Antigenic drift, Antigenic shift, Bio-panning, Epitope characterization, Heterosubtypic immunity, Homologus immunity, Homosubtypic immunity, Monoclonal antibody, Neutralizing antibody, Phage display",
author = "Nicola Clementi and Elena Criscuolo and Matteo Castelli and Massimo Clementi",
year = "2012",
language = "English",
volume = "35",
pages = "399--406",
journal = "New Microbiologica",
issn = "1121-7138",
publisher = "Luigi Ponzio e figlio Editori",
number = "4",

}

TY - JOUR

T1 - Broad-range neutralizing anti-influenza a human monoclonal antibodies

T2 - New perspectives in therapy and prophylaxis

AU - Clementi, Nicola

AU - Criscuolo, Elena

AU - Castelli, Matteo

AU - Clementi, Massimo

PY - 2012

Y1 - 2012

N2 - Broadly neutralizing monoclonal antibodies (mAbs) directed against different subtypes of influenza A viruses are novel tools for the potential development of effective anti-influenza prophylactic and therapeutic strategies. In both cases, the main candidates for passive transfer and new vaccine development are represented by protective mAbs directed against influenza hemagglutinin (HA). A large number of mAbs directed against influenza HA has been developed to date. However, even if they can be useful and contribute to develop new vaccinal strategies, only few of them can be a good candidate for human administration. In this review, we will describe the most relevant human mAb directed against influenza HA able to recognize highly divergent influenza isolates and possibly useful for human therapy and prophylaxis.

AB - Broadly neutralizing monoclonal antibodies (mAbs) directed against different subtypes of influenza A viruses are novel tools for the potential development of effective anti-influenza prophylactic and therapeutic strategies. In both cases, the main candidates for passive transfer and new vaccine development are represented by protective mAbs directed against influenza hemagglutinin (HA). A large number of mAbs directed against influenza HA has been developed to date. However, even if they can be useful and contribute to develop new vaccinal strategies, only few of them can be a good candidate for human administration. In this review, we will describe the most relevant human mAb directed against influenza HA able to recognize highly divergent influenza isolates and possibly useful for human therapy and prophylaxis.

KW - Antigenic drift

KW - Antigenic shift

KW - Bio-panning

KW - Epitope characterization

KW - Heterosubtypic immunity

KW - Homologus immunity

KW - Homosubtypic immunity

KW - Monoclonal antibody

KW - Neutralizing antibody

KW - Phage display

UR - http://www.scopus.com/inward/record.url?scp=84869190870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869190870&partnerID=8YFLogxK

M3 - Article

C2 - 23109007

AN - SCOPUS:84869190870

VL - 35

SP - 399

EP - 406

JO - New Microbiologica

JF - New Microbiologica

SN - 1121-7138

IS - 4

ER -